Filing Flows › Comparisons › VRTX vs BHC
Vertex Pharmaceuticals vs Bausch Health Companies: VRTX and BHC compared
Vertex Pharmaceuticals is the larger company: $3.4B of revenue in its latest quarter (Q3 2026) against $2.9B for Bausch Health Companies (Q3 2026). Vertex Pharmaceuticals is growing faster (+12% against +10% a year earlier). Bausch Health Companies is more profitable, with an operating margin of 33.4% against 20.7%.
Where the money goes: VRTX and BHC
Vertex Pharmaceuticals (VRTX) · Q3 2026
Vertex Pharmaceuticals, Q3 2026: revenue $3.4B (+12% year over year), operating margin 20.7%, net earnings $654M, operating cash flow $643M. The chart follows the revenue to costs, profit and cash.
Bausch Health Companies (BHC) · Q3 2026
Bausch Health Companies, Q3 2026: revenue $2.9B (+10% year over year), operating margin 33.4%, net earnings $436M, operating cash flow $814M. The chart follows the revenue to costs, profit and cash.
| Vertex Pharmaceuticals (VRTX) | Bausch Health Companies (BHC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $3.4B | $2.9B |
| Revenue growth, Y/Y | +12% | +10% |
| Operating margin | 20.7% | 33.4% |
| Net earnings | $654M | $436M |
| Net margin | 19.0% | 14.8% |
| Operating cash flow | $643M | $814M |
| Free cash flow | $546M | $748M |
| Market value | $139.6B | $3.1B |
| P/E | 35.2× | — |
| Analysts’ mean target | $592.36 | $8.00 |
Where the revenue comes from
Vertex Pharmaceuticals
- Total CF product revenues, net: $3.3B (95%)
- CASGEVY: $99.2M (3%)
- JOURNAVX: $58.3M (2%)
Bausch Health Companies
- Product sales: $2.9B (99%)
- Other revenues: $29.0M (1%)
Questions
Which is bigger, Vertex Pharmaceuticals or Bausch Health Companies?
Vertex Pharmaceuticals is the larger company: $3.4B of revenue in its latest quarter (Q3 2026) against $2.9B for Bausch Health Companies (Q3 2026).
Is Vertex Pharmaceuticals or Bausch Health Companies growing faster?
Vertex Pharmaceuticals is growing faster (+12% against +10% a year earlier).
Which is more profitable, Vertex Pharmaceuticals or Bausch Health Companies?
Bausch Health Companies is more profitable, with an operating margin of 33.4% against 20.7%.
More: Vertex Pharmaceuticals earnings · how Vertex Pharmaceuticals makes money · Bausch Health Companies earnings · how Bausch Health Companies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.